Skip to main content
TOI logo
TOI
(NASDAQ)
The Oncology Institute, Inc.
$5.12-- (--)
Loading... - Market loading

The Oncology Institute (TOI) Company Profile

Complete business overview, executive team, trading details, and corporate information.

The Oncology Institute, Inc.
TOINasdaq Stock MarketHealthcareMedical Care Facilities

About The Oncology Institute

The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

Stock Details

ExchangeNasdaq Stock Market (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone562 735 3226
Address
18000 Studebaker Road, Suite 800 Cerritos, California 90703 United States

Corporate Identifiers

CIK0001799191
CUSIP68236X100
ISINUS68236X1000
EIN84-3562323
SIC8011

Leadership Team & Key Executives

Dr. Daniel Virnich FACHE, M.B.A., M.D.
Chief Executive Officer and Executive Director
Robert Carter
Chief Financial Officer
Dr. Yale D. Podnos F.A.C.S., M.D., M.P.H.
Chief Medical Officer
Austin Lee
Vice President of Accounting and Controller
Rakesh Panda
Chief Information Officer
Minh Merchant
Chief Legal Officer
Nolan Mariano
Chief People Officer
Mark Hueppelsheuser Esq.
General Counsel
Jordan McInerney
Chief Development Officer
Stephen Cella
Senior Vice President of Finance